首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >In vitro anti-anaerobic activity of the cephalosporin derivative RWJ 54428, compared to seven other compounds.
【24h】

In vitro anti-anaerobic activity of the cephalosporin derivative RWJ 54428, compared to seven other compounds.

机译:与其他七个化合物相比,头孢菌素衍生物RWJ 54428的体外抗厌氧活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Agar dilution MIC was used to test the activity of RWJ 54428, a new cephalosporin derivative, compared to imipenem, meropenem, ceftriaxone, piperacillin, piperacillin-tazobactam, clindamycin and metronidazole against 363 anaerobes isolated from clinical specimens. RWJ 54428 had low MICs against most beta-lactamase-negative Gram-negative rods, and all Gram-positive strains except Clostridium difficile. Imipenem and meropenem had the lowest MICs (MIC50s of 0.125 mg/L and MIC90s of 1.0 mg/L). Piperacillin-tazobactam, clindamycin and metronidazole were active against most strains, and ceftriaxone was active mainly against beta-lactamase-negative organisms.
机译:琼脂稀释MIC用于测试新的头孢菌素衍生物RWJ 54428与亚胺培南,美罗培南,头孢曲松,哌拉西林,哌拉西林-他唑巴坦,克林霉素和甲硝唑对从临床标本中分离出的363种厌氧菌的活性。 RWJ 54428对大多数β-内酰胺酶阴性革兰氏阴性杆菌以及除艰难梭菌外的所有革兰氏阳性菌具有低MIC。亚胺培南和美罗培南的MIC最低(MIC50为0.125 mg / L,MIC90为1.0 mg / L)。哌拉西林-他唑巴坦,克林霉素和甲硝唑对大多数菌株有活性,而头孢曲松主要对β-内酰胺酶阴性生物有活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号